High Flow Nasal Cannula Market Revenue to Attain USD 18.62 Bn by 2033

25 Sep 2025

Share :

Table of Content

1. High Flow Nasal Cannula  Market Revenue and Trends 2025 to 2033 2. Introduction 3. Growth Factors: 4. High Flow Nasal Cannula Market Report Scope 5. Segments Insights 6. Regional Insights 7. High Flow Nasal Cannula Market Key Players 8. Segments coverd in the Report

High Flow Nasal Cannula  Market Revenue and Trends 2025 to 2033

The global high flow nasal cannula market revenue reached USD 8.21 billion in 2025 and is predicted to attain around USD 18.62 billion by 2033 with a CAGR of 10.62%.

Introduction

The Nasal Cannula (NC) is a system used to provide extra oxygen to a patient or adult in need of respiratory assistance. The nasal cannula contains a lightweight tube, which then divides into two prongs, these separate prongs are placed in the patient's nostrils, from which a mixture of air and oxygen flows. The epidemic of Covid-19 prompted industry players to make advanced high-flow nasal cannulas. In addition, CDC accepted oxygenation therapy of high-flow nasal cannula as a standard and is recommended in the U.S. recommendations for Covid-19 patient care. The sudden rise of the COVID-19 pandemic has led to increasing demand for high-flow nasal cannula due to the growth of the target market has been augmented tremendously.

Growth Factors:

The number of respiratory disorders around the world is growing at an alarming rate, and strict actions to prevent the occurrences of such diseases should be taken by the common people and the government both. Also, now increasing prevalence of COVID-19 across the globe which experience mild to moderate respiratory illness is also creating demand for high-flow nasal cannula.

Non-communicable diseases (NCDs), including cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes, are one of the most prevalent diseases today. As per the WHO report, The Global Impact of Respiratory Disease published in 2017, the number of people suffering from the chronic obstructive pulmonary disease worldwide was approximately 65 million. High-flow oxygen therapy is an advanced technique to treat infant bronchiolitis. Several experimental studies have reported its beneficial physiologic effects, and the clinical experience has been positive.

The PICU (pediatric intensive care unit) admission rates and consequential costs were lower for High Flow than for Low Flow oxygen therapy. High Flow oxygen therapy proved more cost-effective than standard treatment in all baseline analyses and was also more cost-effective in the sensitivity analyses. Nevertheless, emerging markets of high-flow nasal cannula are anticipated to create potential opportunities for the growth of the global high-flow nasal cannula market. 

High Flow Nasal Cannula Market Report Scope

Segments Insights

• Among the product type segment, the active humidifier segment dominated the overall market in 2020, owing to increasing demand in order to treat patients with acute respiratory failure through all age groups. The single-heated tube segment is predicted to grow at a significant CAGR during the forecast time frame. This is due to the nasal cannula’s humidifying properties of the nasopharynx which are essentially used to provide supplemental oxygen. 
• Among the application, the acute respiratory failure segment accounted for a significant share. Growing demand for the target product in this application is boosting the growth of the segment. The chronic respiratory disorder segment is estimated to grow at a significant CAGR during the forecast time frame.
• Among the end-user, the hospitals and clinics segment accounted for a significant share. The ambulatory care centers segment is anticipated to grow at a significant CAGR throughout the forecast time frame.
• On the basis of the sales channel, the distribution channel segment accounted for a significant share. The direct channel segment is projected to grow at a significant CAGR throughout the forecast time frame.  
• Becton Dickinson and Company accounted for a significant share of the global high flow nasal cannula market.

Regional Insights

How North America Dominates the High Flow Nasal Cannula Market Revenue in 2024?

North America dominated the global market revenue in 2024. The market growth in the region is attributed to the increasing availability of nasal cannula products at budget-friendly costs, increasing presence of both international and local manufacturers, increasing prevalence of chronic diseases such as asthma, and COPD, and increasing healthcare expenditure. The U.S. and Canada are dominating countries driving the market growth.

Asia Pacific High Flow Nasal Cannula Market Trends

Asia Pacific is expected to grow fastest during the forecast period. The market growth in the region is driven by factors such as the increasing demand for home healthcare solutions, enhanced accessibility to medical services, increasing healthcare infrastructure, increasing awareness towards respiratory ailments, increasing healthcare spendings and growing substantial population. China, India, Japan and South Korea are the fastest growing countries fueling the market growth in the region.

Key Market Players and Strategies:

The major companies functioning in the worldwide high-flow nasal cannula include Armstrong Medical Ltd, Salter Labs Inc, ResMed, Inc. Teleflex Inc, Apothem Inc. Becton Dickinson, and Company, Smiths Medical, Flex care Medical Ltd, Teijin Pharma Limited. TNI Medical AG, Fisher & Paykel Healthcare Limited, and Hamilton Medical AG among others. Major companies operating in the global high-flow nasal cannula market are investing heavily in the research and development of advanced products. Also, strategic business partnerships like mergers as well as acquisitions in the target industry are expected to boost the market growth during the next 10 years.

High Flow Nasal Cannula Market Key Players

• Armstrong Medical Ltd
• Salter Labs Inc
• ResMed, Inc.
• Teleflex Inc
• Vapotherm Inc.
• Becton Dickinson, and Company
• Smiths Medical
• Flexicare Medical Ltd
• Teijin Pharma Limited
• TNI Medical AG
• Fisher & Paykel Healthcare Limited
• Hamilton Medical AG

Recent Developments

• In September 2024, Oxymed launched P2 portable oxygen concentrator for Indian market. The oxygen concentrator weighs 1.98 kg and delivers oxygen with a purity level 90-95% across all flow rates, ensuring that users receive the essential oxygen support they need.

Segments coverd in the Report

By Product Type

• Single heated tube
• Nasal cannula
• Active humidifier
• Air blender

By Application

• Acute Respiratory Failure
• Chronic Obstructive Pulmonary Disease
• Acute Heart Failure
• Others

By End-user

• Hospitals and clinics
• Ambulatory care centers
• Long-term care centers
• Others

By Sales Channel

• Direct Channel
• Distribution Channel

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/1254

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com |+1 804 441 9344